| Dr Kyle Jarrod Linsey, DO | |
|
610 Lakeview Rd, Clearwater, FL 33756-3336 | |
| (727) 446-7578 | |
| Not Available |
| Full Name | Dr Kyle Jarrod Linsey |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 610 Lakeview Rd, Clearwater, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194164517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | OS12404 (Florida) | Secondary |
| 207W00000X | Ophthalmology | OS016632 (Pennsylvania) | Secondary |
| 207W00000X | Ophthalmology | OS12404 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kyle Linsey Do Pa | 2860744026 | 2 |
News Archive
The Elsevier Foundation, TWAS, the academy of sciences for the developing world and the Organization for Women in Science for the Developing World (OWSD) announced today that they are recognizing eleven talented women scientists from Africa, the Middle East, Asia, Latin America and the Caribbean for their research excellence.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Tackling the increasing rates of cardiovascular disease in developing nations will require input from multiple partners, including the business community and international companies as well as global health and development agencies and the governments of these countries, says a new report from the Institute of Medicine.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide comprehensive obesity registry for bariatrics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.
› Verified 7 days ago
| Entity Name | Larry M Perich Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811920606 PECOS PAC ID: 8224060553 Enrollment ID: O20050907000646 |
News Archive
The Elsevier Foundation, TWAS, the academy of sciences for the developing world and the Organization for Women in Science for the Developing World (OWSD) announced today that they are recognizing eleven talented women scientists from Africa, the Middle East, Asia, Latin America and the Caribbean for their research excellence.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Tackling the increasing rates of cardiovascular disease in developing nations will require input from multiple partners, including the business community and international companies as well as global health and development agencies and the governments of these countries, says a new report from the Institute of Medicine.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide comprehensive obesity registry for bariatrics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.
› Verified 7 days ago
| Entity Name | Kyle Linsey Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558847541 PECOS PAC ID: 2860744026 Enrollment ID: O20181016003820 |
News Archive
The Elsevier Foundation, TWAS, the academy of sciences for the developing world and the Organization for Women in Science for the Developing World (OWSD) announced today that they are recognizing eleven talented women scientists from Africa, the Middle East, Asia, Latin America and the Caribbean for their research excellence.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Tackling the increasing rates of cardiovascular disease in developing nations will require input from multiple partners, including the business community and international companies as well as global health and development agencies and the governments of these countries, says a new report from the Institute of Medicine.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide comprehensive obesity registry for bariatrics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kyle Jarrod Linsey, DO 13930 Shady Shores Dr, Tampa, FL 33613-1900 Ph: (813) 382-7022 | Dr Kyle Jarrod Linsey, DO 610 Lakeview Rd, Clearwater, FL 33756-3336 Ph: (727) 446-7578 |
News Archive
The Elsevier Foundation, TWAS, the academy of sciences for the developing world and the Organization for Women in Science for the Developing World (OWSD) announced today that they are recognizing eleven talented women scientists from Africa, the Middle East, Asia, Latin America and the Caribbean for their research excellence.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Tackling the increasing rates of cardiovascular disease in developing nations will require input from multiple partners, including the business community and international companies as well as global health and development agencies and the governments of these countries, says a new report from the Institute of Medicine.
RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide comprehensive obesity registry for bariatrics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.
Dynatronics Corporation today announced results for its fiscal third quarter ended March 31, 2010. Sales for the quarter increased 7.9 percent to $8,235,060, compared to $7,633,419 for the third quarter of the prior fiscal year. For the nine-month period ended March 31, 2010, sales increased 2.8 percent to $25,018,960, compared to $24,348,461 for the same period in the prior fiscal year.
› Verified 7 days ago
Kendra Denise Deangelis, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2963 Gulf To Bay Blvd Ste 267, Clearwater, FL 33759 Phone: 787-285-8006 Fax: 727-216-6560 | |
Mr. Dana M Deupree, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3280 N Mcmullen Booth Rd, Suite 120, Clearwater, FL 33761 Phone: 727-789-8770 Fax: 727-789-8784 | |
Steven Myles Cohen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 579 S Duncan Ave, Clearwater, FL 33756 Phone: 727-445-9110 Fax: 727-466-0306 | |
Samantha Nastasi, Ophthalmology Medicare: Medicare Enrolled Practice Location: 601 S Belcher Rd, Clearwater, FL 33764 Phone: 727-266-2393 Fax: 727-266-2330 | |
Dr. Scott Behler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2346 Drew St, Clearwater, FL 33765 Phone: 727-712-2500 Fax: 727-712-2511 | |
Dr. Selina Jia-hwa Lin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3001 Eastland Blvd Ste 1, Clearwater, FL 33761 Phone: 833-733-3754 | |
Mr. Herbert P Knauf Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2560 Gulf To Bay Blvd, Suite 100, Clearwater, FL 33765 Phone: 727-799-3772 Fax: 727-791-6598 |